These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 2758872)
41. Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan. Chiu CH; Lee HY; Tseng LY; Chen CL; Chia JH; Su LH; Liu SY Int J Antimicrob Agents; 2010 Apr; 35(4):382-6. PubMed ID: 20138741 [TBL] [Abstract][Full Text] [Related]
42. In-vitro and in-vivo activities of antimicrobial agents against Acinetobacter calcoaceticus. Obana Y; Nishino T; Tanino T J Antimicrob Chemother; 1985 Apr; 15(4):441-8. PubMed ID: 4008377 [TBL] [Abstract][Full Text] [Related]
43. [Antibiotic resistance of Acinetobacter baumannii isolates: data from Ibni Sina Hospital for the year 2002]. Akan OA Mikrobiyol Bul; 2003 Oct; 37(4):241-6. PubMed ID: 14748260 [TBL] [Abstract][Full Text] [Related]
44. [Problem of treatment for pyo-inflammatory complications caused by Acinetobacter]. Bogomolova NS; Bol'shakov LV; Kuznetsova SM Anesteziol Reanimatol; 2014; (1):26-32. PubMed ID: 24749305 [TBL] [Abstract][Full Text] [Related]
45. Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex. Huang YS; Wang JT; Sheng WH; Chuang YC; Chang SC J Microbiol Immunol Infect; 2015 Oct; 48(5):545-51. PubMed ID: 24662017 [TBL] [Abstract][Full Text] [Related]
46. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin. Dueñas Díez AI; Bratos Pérez MA; Eiros Bouza JM; Almaraz Gómez A; Gutiérrez Rodríguez P; Miguel Gómez MA; Orduña Domingo A; Rodríguez-Torres A Int J Antimicrob Agents; 2004 May; 23(5):487-93. PubMed ID: 15120728 [TBL] [Abstract][Full Text] [Related]
47. Comparison of in vitro activities of levofloxacin, ciprofloxacin, ceftazidime, cefepime, imipenem, and piperacillin-tazobactam against aerobic bacterial pathogens from patients with nosocomial infections. Huang SS; Lee SC; Lee N; See LC; Tsai MH; Shieh WB J Microbiol Immunol Infect; 2007 Apr; 40(2):134-40. PubMed ID: 17446961 [TBL] [Abstract][Full Text] [Related]
48. In vitro activity of ampicillin-sulbactam against clinical multiresistant Acinetobacter baumannii isolates. Gales AC; Sader HS; Sinto S; Santos OP; Mendes CM J Chemother; 1996 Dec; 8(6):416-9. PubMed ID: 8981180 [TBL] [Abstract][Full Text] [Related]
49. [E-test to study small inhibitor concentrations, bacterial diversity and to identify presumptively beta-lactamases in strains of Pseudomonas aeruginosa and Acinetobacter baumannii associated with +nosocomial infections]. Triantafilo V; Fica A; Silva M; Thompson L Rev Med Chil; 1997 Feb; 125(2):149-60. PubMed ID: 9430934 [TBL] [Abstract][Full Text] [Related]
50. [Analysis of drug resistance of Pseudomonas aeruginosa and use of antibiotics in burn wards during 6 years]. Dou Y; Zhang Q Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):9-14. PubMed ID: 24684983 [TBL] [Abstract][Full Text] [Related]
51. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii. Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581 [TBL] [Abstract][Full Text] [Related]
52. Susceptibility of Xanthomonas maltophilia and amikacin-resistant gram-negative bacteria to newer antimicrobials. Matsuyama JR; Beail B; Wallis C; Zeleznik D; Tartaglione T Clin Pharm; 1991 Jul; 10(7):544-8. PubMed ID: 1860303 [TBL] [Abstract][Full Text] [Related]
53. [Comparison of the in vitro activity of amikacin, netilmicin, piperacillin and moxalactam against Acinetobacter calcoaceticus var. anitratum]. Gamazo C; Urra E; Apraiz D; Angel Montañés M Med Clin (Barc); 1985 Nov; 85(16):659-60. PubMed ID: 4079560 [No Abstract] [Full Text] [Related]
54. Phage-types and susceptibility to 26 antibiotics of nosocomial strains of Acinetobacter isolated in Portugal. Santos Ferreira MO; Vieu JF; Klein B J Int Med Res; 1984; 12(6):364-8. PubMed ID: 6519351 [TBL] [Abstract][Full Text] [Related]
55. Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem, Israel. Simhon A; Rahav G; Shazberg G; Block C; Bercovier H; Shapiro M J Clin Microbiol; 2001 Jan; 39(1):389-91. PubMed ID: 11136809 [TBL] [Abstract][Full Text] [Related]
56. Pseudomonas aeruginosa isolated from corneal ulcer: susceptibility to antimicrobial agents tested alone or in combination. Hu FR; Luh KT J Formos Med Assoc; 1992 Feb; 91(2):190-4. PubMed ID: 1364217 [TBL] [Abstract][Full Text] [Related]
57. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance. Lee K; Park KH; Jeong SH; Lim HS; Shin JH; Yong D; Ha GY; Chong Y; KONSAR group Yonsei Med J; 2006 Feb; 47(1):43-54. PubMed ID: 16502484 [TBL] [Abstract][Full Text] [Related]
58. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005]. Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265 [TBL] [Abstract][Full Text] [Related]
59. [Identification and sensitivity of acinetobacter sp isolated from clinical specimens and hospital environment]. Martínez MA; Pinto ME; Giglio MS; Pommier J; Muñoz LM Rev Med Chil; 1992 Nov; 120(11):1267-72. PubMed ID: 1340947 [TBL] [Abstract][Full Text] [Related]
60. Prevalence and antimicrobial susceptibility of Acinetobacter from raw bulk tank milk in Korea. Gurung M; Nam HM; Tamang MD; Chae MH; Jang GC; Jung SC; Lim SK J Dairy Sci; 2013 Apr; 96(4):1997-2002. PubMed ID: 23462164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]